Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HCA Healthcare (HCA)

HCA Healthcare adopts 2025 executive bonus program tied 80% to EBITDA; director Crofton retiring

Neutral Impact 2 of 5 leadership Written later

HCA Healthcare's Compensation Committee adopted a 2025 Executive Officer Performance Excellence Program, a cash incentive plan weighted 80% on EBITDA targets and 20% on quality metrics. Director Meg G. Crofton also said she will not stand for re-election and will retire from the board at the April 24, 2025 annual meeting. The filing discloses plan structure and targets but no financial results, so it does not change reported earnings.

Key points

  • Executive Officer PEP adopted February 18, 2025; awards weighted 80% EBITDA and 20% quality metrics
  • Target awards: 175% of base salary for CEO Samuel N. Hazen; 125% for CFO Michael A. Marks and COO Jon M. Foster
  • Quality portion split: Healthcare-Associated Infections and Sepsis 30%, Complication and Mortality 30%, Care Experience 40%; no quality payment if EBITDA is below 90% of target
  • Director Meg G. Crofton informed the company on February 19, 2025 that she will retire effective at the April 24, 2025 annual meeting

The filing

CompanyHCA Healthcare (HCA)
Form8-K, current report
Filed with the SECFeb 24, 2025, 4:19 PM ET
Accession number0001193125-25-033430

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.